Evaluation of 3 Oral Self-care Regimens on Clinical Signs of Inflammation and Plaque
NCT ID: NCT05766995
Last Updated: 2023-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2021-08-03
2021-09-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Compare the Effectiveness of Three Self-care Oral Hygiene Regimens
NCT04804670
Measuring Efficacy of an Oral-Irrigator After Three Weeks of Use
NCT04899440
Efficacy of Dental Hygiene Aids in Reducing Gingival Bleeding and Plaque Among Orthodontic Patients.
NCT06554938
Efficacy of the Addition of a Power Interdental Device to an Electric Toothbrush on Gingival Health.
NCT04003298
Efficacy and Safety Study of Interproximal Cleaning Modalities on Oral Health
NCT02187016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Is there a difference between the two water flosser devices on gum bleeding scores?
* Is there a difference between the two water flosser devices on plaque accumulation and removal?
* Is there a difference between the two water flosser devices on signs of gingivitis?
Researchers will compare the two groups using a water flosser (experimental) to see how it compares to traditional brushing and flossing (control).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Manual toothbrush and water flosser with standard jet tip
Brush with a standard ADA manual toothbrush twice daily followed by water flossing once in the evening
Waterpik Water Flosser
A pulsating water flosser and jet tip designed to clean between the teeth and below the gingival margin.
Manual toothbrush and water flosser with targeted jet tip
Brush with a standard ADA manual toothbrush twice daily followed by water flossing once in the evening
Oral-B Water Flosser
A water flosser and specialized tip that delivers water with microbubbles of air
Manual toothbrush and dental floss
Brush with a standard ADA manual toothbrush twice daily followed by dental flossing once in the evening
Waxed Dental Floss
Nylon string used to clean between the teeth manually
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Waterpik Water Flosser
A pulsating water flosser and jet tip designed to clean between the teeth and below the gingival margin.
Oral-B Water Flosser
A water flosser and specialized tip that delivers water with microbubbles of air
Waxed Dental Floss
Nylon string used to clean between the teeth manually
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be between 18 and 75 years of age, male or female.
* Have at least twenty (20) natural teeth (5 evaluable in each quadrant) with scorable facial and lingual surfaces as determined by the clinical examiner.
* Nonsmoking (assessed as \< 1 cigarette every day for at least a year).
* Have a mean baseline plaque index score of ≥0.60 as determined by the Rustogi Modification of the Navy Plaque Index (RMNPI).
* Have a mean baseline gingival index score of ≥1.75 as determined by the Modified Gingival Index (MGI).
* Have a mean bleeding on probing score of 50%.
* Have probe readings ≤4 mm.
* Agree not to have a dental prophylaxis or any other elective, non-emergency dental procedures any time during the study.
* Agree to abstain from the use of chewing gum, mouth rinses, any toothpaste other than the study toothpaste, tooth whitening products (either professional or at home use) and all other oral hygiene other than the study procedures for the duration of the study.
* Agree to refrain from all oral hygiene on the morning of each evaluation visit and to refrain from eating, drinking or chewing gum for 4 hours prior to each evaluation visit.
* Agree to comply with the conditions and schedule of the study.
Exclusion Criteria
* Evidence of gross oral pathology, including widespread caries or chronic neglect, extensive restoration, pre-existing gross plaque or soft or hard tissue tumor of the oral cavity.
* Supra- or subgingival calculus that might interfere with evaluations as determined by the clinical examiner.
* Evidence of major oral hard or soft tissue lesions or trauma at the baseline visit as determined by the clinical examiner.
* Conditions requiring antibiotic treatment prior to dental procedures.
* History of uncontrolled diabetes or hepatic or renal disease, or other serious conditions or transmittable disease, (e.g. COVID-19, AIDS).
* Subjects with grossly carious, fully crowned, or extensively restored teeth, orthodontic appliances, peri/oral piercings, or removable partial dentures.
* Treatment with antibiotics within the 1-month period before the baseline examination, or a condition that is likely to require antibiotic treatment over the course of the trial.
* Chronic treatment (2-weeks or more) with any medication known to affect periodontal status (including phenytoin, calcium antagonists, cyclosporine, Coumadin, nonsteroidal anti-inflammatory drugs, and aspirin (325 mg)) within 1- month of the baseline examination. All other medications for chronic medical conditions must have been initiated at least 3 months before enrollment.
* Have moderate to severe periodontal disease or being actively treated for periodontal disease.
* Concomitant periodontal therapy other than prophylaxis in the last 6 months.
* Professional prophylaxis within 1 month prior to the baseline clinical evaluation.
* Subjects who participate in a gingivitis study in the past month.
* History of significant adverse event following use of oral hygiene products such as toothpastes and mouth rinses.
* Subjects who are allergic to any ingredients in Crest® Cavity Protection or Colgate® Cavity Protection toothpaste.
* Self-reported pregnancy or lactating women since hormonal changes can exaggerate gingival response to dental plaque.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Water Pik, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deborah Mancinelli Lyle
Role: PRINCIPAL_INVESTIGATOR
Water Pik, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
All Sum Research Center Ltd.
Mississauga, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-WP-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.